Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 99-102 , April 2010

Stereotactic fractionated radiotherapy for Klatskin tumours

  • Felix Momm

      Affiliations

    • University Hospital Freiburg, Department of Radiation Oncology, Freiburg i. Br., Germany
    • Corresponding Author InformationCorresponding author. Address: Universitätsklinikum Freiburg, Klinik für Strahlenheilkunde, Robert-Koch-Str. 3, 79106 Freiburg, Germany.
    • ,
  • Eva Schubert

      Affiliations

    • University Hospital Freiburg, Department of Radiation Oncology, Freiburg i. Br., Germany
    • ,
  • Karl Henne

      Affiliations

    • University Hospital Freiburg, Department of Radiation Oncology, Freiburg i. Br., Germany
    • ,
  • Norbert Hodapp

      Affiliations

    • University Hospital Freiburg, Department of Radiation Oncology, Freiburg i. Br., Germany
    • ,
  • Hermann Frommhold

      Affiliations

    • University Hospital Freiburg, Department of Radiation Oncology, Freiburg i. Br., Germany
    • ,
  • Jan Harder

      Affiliations

    • University Hospital Freiburg, Department of Gastroenterology and Hepatology, Freiburg i. Br., Germany
    • ,
  • Anca-Ligia Grosu

      Affiliations

    • University Hospital Freiburg, Department of Radiation Oncology, Freiburg i. Br., Germany
    • ,
  • Gerhild Becker

      Affiliations

    • University Hospital Freiburg, Department of Gastroenterology and Hepatology, Freiburg i. Br., Germany

Received 30 November 2009 ,Revised 24 February 2010 ,Accepted 7 March 2010.

References 

  1. Khan SA, Thomas HC, Davidson BR, et al. Cholangiocarcinoma. Lancet. 2005;366:1303–1314
  2. Todoroki T, Kawamoto T, Koike N, et al. Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg. 2000;87:306–313
  3. Ito F, Cho CS, Rikkers LF, et al. Hilar cholangiocarcinoma: current management. Ann Surg. 2009;250:210–218
  4. Burke EC, Jarnagin WR, Hochwald SN, et al. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg. 1998;228:385–394
  5. Reding R, Buard JL, Lebeau G, et al. Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey. Ann Surg. 1991;213:236–241
  6. Ben-David MA, Griffith KA, Abu-Isa E, et al. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2006;66:772–779
  7. Alden ME, Mohiuddin M. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys. 1994;28:945–951
  8. Morganti AG, Trodella L, Valentini V, et al. Combined modality treatment in unresectable extrahepatic biliary carcinoma. Int J Radiat Oncol Biol Phys. 2000;46:913–919
  9. Becker G, Momm F, Schwacha H, et al. Klatskin tumor treated by interdisciplinary therapies including stereotactic radiotherapy: a case report. World J Gastroenterol. 2005;11:4923–4926
  10. Haedinger U, Thiele W, Wulf J. Extracranial stereotactic radiotherapy: evaluation of PTV coverage and dose conformity. Z Med Phys. 2002;12:221–229
  11. Blomgren H, Lax I, Näslund I, et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol. 1995;34:861–870
  12. Buchmann I, Ganten TM, Haberkorn U. [18F]-FDG-PET in the diagnostics of gastrointestinal tumors. Z Gastroenterol. 2008;46:367–375
  13. Hodapp N, Nanko N, Nestle U, et al. The Freiburg patient positioning and fixation concept for precision radiotherapy. Strahlenther Onkol. 2009;185(Supp 1):126
  14. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation. 2000;69:1633–1637
  15. Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242:451–458
  16. Kaiser GM, Sotiropoulos GC, Jauch KW, et al. Liver transplantation for hilar cholangiocarcinoma: a German survey. Transplant Proc. 2008;40:3191–3193
  17. Park JY, Park SW, Chung JB, et al. Concurrent chemoradiotherapy with doxifluridine and paclitaxel for extrahepatic bile duct cancer. Am J Clin Oncol. 2006;29:240–245
  18. Crane CH, Macdonald KO, Vauthey JN, et al. Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol Biol Phys. 2002;53:969–974
  19. Foo ML, Gunderson LL, Bender CE, et al. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1997;39:929–935
  20. Vallis KA, Benjamin IS, Munro AJ, et al. External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability. Radiother Oncol. 1996;41:61–66
  21. Robertson JM, Lawrence TS, Andrews JC, et al. Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers. Int J Radiat Oncol Biol Phys. 1997;37:325–330
  22. Robertson JM, Lawrence TS, Dworzanin LM, et al. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol. 1993;11:1286–1293
  23. Kamada T, Saitou H, Takamura A, et al. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys. 1996;34:767–774
  24. Takamura A, Saito H, Kamada T, et al. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys. 2003;57:1357–1365
  25. Kaiser GM, Frühauf NR, Lang H, et al. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma. Hepatogastroenterology. 2008;55:1951–1954
  26. Shin HS, Seong J, Kim WC, et al. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts. Int J Radiat Oncol Biol Phys. 2003;57:105–112
  27. Ben-Josef E, Normolle D, Ensminger WD, et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol. 2005;23:8739–8747
  28. Schleicher UM, Staatz G, Alzen G, et al. Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors. Strahlenther Onkol. 2002;178:682–687
  29. Gerhards MF, van Gulik TM, González González D, et al. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg. 2003;27:173–179
  30. Ortner MA, Caca K, Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology. 2003;125:1355–1363
  31. Li J, Kuehl H, Grabellus F, et al. Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT. J Surg Oncol. 2008;98:438–443
  32. Weber A, Schmid RM, Prinz C. Diagnostic approaches for cholangiocarcinoma. World J Gastroenterol. 2008;14:4131–4136
  33. Masselli G, Manfredi R, Vecchioli A, et al. MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings. Eur Radiol. 2008;18:2213–2221

PII: S0167-8140(10)00168-4

doi: 10.1016/j.radonc.2010.03.013

Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 99-102 , April 2010

Article Tools

* Image Usage & Resolution